trilostane has been researched along with Adrenal Cancer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D; Lee, GW; Park, HM; Yoo, CR | 1 |
| Chai, SH; Kim, WH; Kweon, OK; Lee, A; Lee, S | 1 |
| Kimura, M; Nakada, T | 1 |
| Katayama, T; Nakada, T | 1 |
| Anderson, DC; Bu'lock, DE; Dewis, P; Earnshaw, R; Kelly, WF | 1 |
| Bricaire, H; Luton, JP | 1 |
| Füessl, HS | 1 |
| Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M | 1 |
| Greminger, P; Groth, H; Vetter, H; Vetter, W; Winterberg, B | 1 |
9 other study(ies) available for trilostane and Adrenal Cancer
| Article | Year |
|---|---|
Favorable outcome of pheochromocytoma in a dog with atypical Cushing's syndrome and diabetes mellitus following medical treatment: a case report.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Cushing Syndrome; Diabetes Mellitus; Dihydrotestosterone; Dog Diseases; Dogs; Hypoglycemic Agents; Insulin; Male; Phenoxybenzamine; Pheochromocytoma; Treatment Outcome | 2020 |
Ectopic Cushing's syndrome associated with a pheochromocytoma in a dog: a case report.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Male; Phenoxybenzamine; Pheochromocytoma | 2020 |
Primary aldosteronism associated with chronic renal failure. Report of a case.
Topics: Adenoma; Adrenal Gland Neoplasms; Combined Modality Therapy; Dihydrotestosterone; Furosemide; Humans; Hyperaldosteronism; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1984 |
[Therapeutic experience of primary aldosteronism associated with chronic renal failure].
Topics: Adrenal Gland Neoplasms; Dihydrotestosterone; Furosemide; Humans; Hyperaldosteronism; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1983 |
Experience with trilostane in the treatment of Cushing's syndrome.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cushing Syndrome; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Male; Middle Aged | 1983 |
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Androstanols; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mitotane; Nitriles | 1980 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Syndrome; Diagnosis, Differential; Dihydrotestosterone; Diuretics; Enzyme Inhibitors; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Angiography; Mineralocorticoid Receptor Antagonists; Pituitary Neoplasms; Spironolactone; Tomography, X-Ray Computed | 2002 |
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Female; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors; Progesterone; Radioimmunoassay; Renin-Angiotensin System; Testosterone | 1985 |
Primary aldosteronism: treatment with trilostane.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Blood Pressure; Dihydrotestosterone; Electrolytes; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; Male; Middle Aged; Renin-Angiotensin System | 1985 |